Publikationen 2004

  • [Polymyalgia rheumatica (arteritica)] (MMW Fortschr Med)
    Pongratz D
  • Missense mutations of ACTA1 cause dominant congenital myopathy with cores. (J Med Genet)
    Kaindl AM, Rüschendorf F, Krause S, Goebel HH, Koehler K, Becker C, Pongratz D, Müller-Höcker J, Nürnberg P, Stoltenburg-Didinger G, Lochmüller H, Huebner A
  • A newly identified chromosomal microdeletion of the rapsyn gene causes a congenital myasthenic syndrome. (Neuromuscul Disord)
    Müller JS, Abicht A, Christen HJ, Stucka R, Schara U, Mortier W, Huebner A, Lochmüller H
  • Mutation history of the roma/gypsies. (Am J Hum Genet)
    Morar B, Gresham D, Angelicheva D, Tournev I, Gooding R, Guergueltcheva V, Schmidt C, Abicht A, Lochmuller H, Tordai A, Kalmar L, Nagy M, Karcagi V, Jeanpierre M, Herczegfalvi A, Beeson D, Venkataraman V, Warwick Carter K, Reeve J, de Pablo R, Kucinskas V, Kalaydjieva L
  • Homozygosity for CCTG mutation in myotonic dystrophy type 2. (Brain)
    Schoser BG, Kress W, Walter MC, Halliger-Keller B, Lochmüller H, Ricker K
  • The congenital myasthenic syndrome mutation RAPSN N88K derives from an ancient Indo-European founder. (J Med Genet)
    Müller JS, Abicht A, Burke G, Cossins J, Richard P, Baumeister SK, Stucka R, Eymard B, Hantaï D, Beeson D, Lochmüller H
  • The long-term outcome of anti-Jo-1-positive inflammatory myopathies. (J Neurol)
    Späth M, Schröder M, Schlotter-Weigel B, Walter MC, Hautmann H, Leinsinger G, Pongratz D, Müller-Felber W
  • Spontaneous recovery of a childhood onset mitochondrial myopathy caused by a stop mutation in the mitochondrial cytochrome c oxidase III gene. (J Med Genet)
    Horváth R, Lochmüller H, Hoeltzenbein M, Müller-Höcker J, Schoser BG, Pongratz D, Jaksch M
  • Synaptic congenital myasthenic syndrome in three patients due to a novel missense mutation (T441A) of the COLQ gene. (Neuropediatrics)
    Müller JS, Petrova S, Kiefer R, Stucka R, König C, Baumeister SK, Huebner A, Lochmüller H, Abicht A
  • Respiratory insufficiency as a presenting symptom of LGMD2D in adulthood. (Acta Myol)
    Walter MC, Dekomien G, Schlotter-Weigel B, Reilich P, Pongratz D, Müller-Felber W, Epplen JT, Huebner A, Lochmüller H
  • FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients. (J Med Genet)
    Walter MC, Petersen JA, Stucka R, Fischer D, Schröder R, Vorgerd M, Schroers A, Schreiber H, Hanemann CO, Knirsch U, Rosenbohm A, Huebner A, Barisic N, Horvath R, Komoly S, Reilich P, Müller-Felber W, Pongratz D, Müller JS, Auerswald EA, Lochmüller H
  • Consensus statement: botulinum toxin in myofascial [corrected] pain. (J Neurol)
    Reilich P, Fheodoroff K, Kern U, Mense S, Seddigh S, Wissel J, Pongratz D
  • Muscle pathology in 57 patients with myotonic dystrophy type 2. (Muscle Nerve)
    Schoser BG, Schneider-Gold C, Kress W, Goebel HH, Reilich P, Koch MC, Pongratz DE, Toyka KV, Lochmüller H, Ricker K
  • Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia. (Scand J Rheumatol)
    Späth M, Stratz T, Neeck G, Kötter I, Hammel B, Amberger CC, Haus U, Färber L, Pongratz D, Müller W
  • Concluding remarks and outlook for the use of 5-HT3 receptor antagonists in rheumatology. (Scand J Rheumatol Suppl)
    Pongratz D, Stratz T, Müller W
  • Treatment of fibromyalgia with tropisetron--dose and efficacy correlations. (Scand J Rheumatol Suppl)
    Späth M, Stratz T, Färber L, Haus U, Pongratz D